August 16, 2018
Leo Pharma has agreed to acquire Bayer's global prescription dermatology unit, and Almirall will acquire Allergan's US portfolio of medical dermatology drugs. When it comes to patient engagement, aesthetic practices often have the right mindset, but they may lack the skills or time necessary to execute a successful strategy. Those are findings from a survey from eRelevance. The FDA has approved IV Poteligeo injection (Kyowa Kirin) for the treatment of adult patients with either relapsed or refractory mycosis fungoides or Sézary syndrome, after at least one prior systemic therapy.